Exact Mass: 476.2131708

Exact Mass Matches: 476.2131708

Found 500 metabolites which its exact mass value is equals to given mass value 476.2131708, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Loperamide

4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide

C29H33ClN2O2 (476.22304280000003)

Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids; Loperamide usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; Treatment should be avoided in the presence of fever or if the stool is bloody. Treatment is not recommended for patients who could suffer detrimental effects from rebound constipation. If there is a suspicion of diarrhea associated with organisms that can penetrate the intestinal walls, such as E. coli O157:H7 or salmonella, loperamide is contraindicated; Loperamide, usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; it does not affect the central nervous system like other opioids; One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally; Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines [HMDB] Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids; Loperamide usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; Treatment should be avoided in the presence of fever or if the stool is bloody. Treatment is not recommended for patients who could suffer detrimental effects from rebound constipation. If there is a suspicion of diarrhea associated with organisms that can penetrate the intestinal walls, such as E. coli O157:H7 or salmonella, loperamide is contraindicated; Loperamide, usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; it does not affect the central nervous system like other opioids; One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally; Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals KEIO_ID L047; [MS2] KO009036 KEIO_ID L047

2-Methoxyestrone 3-glucuronide

3,4,5-trihydroxy-6-{[(1S,10R,11S,15S)-4-methoxy-15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-5-yl]oxy}oxane-2-carboxylic acid

C25H32O9 (476.2046222)

2-Methoxyestrone 3-glucuronide belongs to the class of organic compounds known as steroid glucuronide conjugates. These are sterol lipids containing a glucuronide moiety linked to the steroid skeleton. Thus, 2-methoxyestrone 3-glucuronide is considered to be a steroid conjugate lipid molecule. 2-Methoxyestrone 3-glucuronide is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. 2-Methoxyestrone 3-glucuronide is a natural human metabolite of 2-methoxyestrone generated in the liver by UDP glucuronosyltransferase. 2-Methoxyestrone is a metabolite of 2-hydroxyestrone (a nonuterotrophic metabolite of estradiol). Glucuronidation is used to assist in the excretion of toxic substances, drugs, or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 2-Methoxyestrone 3-glucuronide is a natural human metabolite of 2-Methoxyestrone generated in the liver by UDP glucuonyltransferase. A glucuronide conjugate of 2-methodxyestrone formed by UDP-glucuronylstransferase (UTP). 2-methoxyestrone is a metabolite of 2-hydroxyestrone (a nonuterotrophic metabolite of estradiol) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

Fuscaxanthone A

7-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-5,9-dihydroxy-8-methoxy-2,2-dimethyl-2,6-dihydro-1,11-dioxatetracen-6-one

C29H32O6 (476.2198772)

2-(4-Methyl-3-pentenyl)-2-methyl-5,10-dihydroxy-9-methoxy-12-(1,1-dimethyl-2-propenyl)-2H,6H-pyrano[3,2-b]xanthene-6-one

C29H32O6 (476.2198772)

9alpha-(2,3-epoxy-2-methylbutyryloxy)-divaricatolide-8-O-(2R,3R-epoxy-2-methylbutyrate)|9alpha-<2,3-epoxy-2-methylbutyryloxy>-divaricatolide-8-O-<2R,3R-epoxy-2-methylbutyrate>

C25H32O9 (476.2046222)

9alpha-angeloyloxy-2alpha-hydroxy-divaricatolide-8-O-<2S,3S-epoxy-2-methylbutyrate>

C25H32O9 (476.2046222)

Dehydroailanthinone

C25H32O9 (476.2046222)

(2R,3S,4R,6R,7R,8R,10R,11R,14S*)-3-angelyloxy-9-hydroxy-14-(3-hydroxy-3-methylbutanoyloxy)-14,15-epoxytrix-5(15)-en-4,12-olide

(2R*,3S*,4R*,6R*,7R*,8R*,10R*,11R*,14S*)-3-angelyloxy-9-hydroxy-14-(3-hydroxy-3-methylbutanoyloxy)-14,15-epoxytrix-5(15)-en-4,12-olide

C25H32O9 (476.2046222)

Fuscaxanthone A

C29H32O6 (476.2198772)

Schkuhripinnatolide C

C25H32O9 (476.2046222)

9beta-hydroxy-1beta,8beta-di-(2,3-epoxy-2-methylbutyryloxy)-6-epi-alpha-cyclocostunolide|9beta-hydroxy-1beta,8beta-di-<2,3-epoxy-2-methylbutyryloxy>-6-epi-alpha-cyclocostunolide

C25H32O9 (476.2046222)

Caruilignan A

C25H32O9 (476.2046222)

8beta-<5-(4,5-dihydroxytigloyloxy)-tigloyloxy>-nobilin

C25H32O9 (476.2046222)

(7R,8S)-cedrusinin-4-O-alpha-L-rhamnoside

C25H32O9 (476.2046222)

saurucinol D

C25H32O9 (476.2046222)

saurucinol E

C25H32O9 (476.2046222)

6alpha-tigloyloxychaparrinone

C25H32O9 (476.2046222)

2-Hydroxyoestron-3-methylether-2-glucuronid

C25H32O9 (476.2046222)

7,7-dimethyl-5,7-epoxypyrano[3,3:2,3]-2-(3-methyl-but-2-enyl)-dibenzo[b,f]pyrano[2,3-d]oxepin-3,7-diol|artocarpol F

C29H32O6 (476.2198772)

Cowaxanthone C

C29H32O6 (476.2198772)

(2R,3R)-2,3-dihydro-3-hydroxymethyl-7-methoxy-2-(3-methoxy-4-alpha-L-rhamnopyranosyloxyphenyl)-5-benxofuranpropanol

C25H32O9 (476.2046222)

10alpha-hydroxy-8beta-<5-(4-hydroxytigloyl)-4-hydroxytigloyloxy>-guaia-3,11(13)-dien-12,6alpha-olide|10alpha-hydroxy-8beta-[5-(4-hydroxytigloyl)-4-hydroxytigloyloxy]-guaia-3,11(13)-dien-12,6alpha-olide

10alpha-hydroxy-8beta-<5-(4-hydroxytigloyl)-4-hydroxytigloyloxy>-guaia-3,11(13)-dien-12,6alpha-olide|10alpha-hydroxy-8beta-[5-(4-hydroxytigloyl)-4-hydroxytigloyloxy]-guaia-3,11(13)-dien-12,6alpha-olide

C25H32O9 (476.2046222)

Oestriol diacetate benzoate

C29H32O6 (476.2198772)

3-desacetyl-5-(4-hydroxytigloyloxy)-eupaformosanin

C25H32O9 (476.2046222)

Val Glu Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]-3-hydroxybutanamido]pentanedioic acid

C19H32N4O10 (476.2118332)

Asp Ser Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]hexanoic acid

C18H32N6O9 (476.22306620000006)

Ser Glu Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carboxybutanamido]-3-methylpentanamido]pentanedioic acid

C19H32N4O10 (476.2118332)

Ser Leu Glu Asp

C19H32N4O10 (476.2118332)

Thr Asn Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]hexanoic acid

C18H32N6O9 (476.22306620000006)

Asp Leu Ser Glu

C19H32N4O10 (476.2118332)

1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one

NCGC00179791-03!1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one

C25H32O9 (476.2046222)

loperamide

C29H33ClN2O2 (476.22304280000003)

A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals CONFIDENCE standard compound; INTERNAL_ID 2504 CONFIDENCE standard compound; INTERNAL_ID 8489

C26H28N4O5_1H-Imidazo[1,2-a]indole-9-propanoic acid, 2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-alpha-(4-oxo-3(4H)-quinazolinyl)-, methyl ester

NCGC00381141-01_C26H28N4O5_1H-Imidazo[1,2-a]indole-9-propanoic acid, 2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-alpha-(4-oxo-3(4H)-quinazolinyl)-, methyl ester

C26H28N4O5 (476.2059598)

1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one

C25H32O9 (476.2046222)

platyphylloside

1,7-Bis(4-hydroxyphenyl)-5-oxo-3-heptanyl ?-D-glucopyranoside

C25H32O9 (476.2046222)

1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one [IIN-based: Match]

NCGC00179791-03!1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one [IIN-based: Match]

C25H32O9 (476.2046222)

1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one [IIN-based on: CCMSLIB00000845973]

NCGC00179791-03!1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one [IIN-based on: CCMSLIB00000845973]

C25H32O9 (476.2046222)

1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one_major

C25H32O9 (476.2046222)

Ala Cys Gln Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C17H32N8O6S (476.21654120000005)

Ala Cys Arg Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C17H32N8O6S (476.21654120000005)

Ala Met Gln Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid